Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Pharmos' neuroprotectant shows additional utility in IBD and anorexia

May 26, 1998

Synsorb Biotech expands phase II trial of Synsorb Cd

May 26, 1998

Long-term efficacy of lamivudine in hepatitis B; overview of antihepatitis research in U.S.

May 26, 1998

Oral tolerization proves effective in experimental rat model of colitis

May 25, 1998

Preclinical efficacy in multiple gastrointestinal disorders reported for ALX-0600

May 22, 1998

Alosetron emerging as safe and effective treatment for IBS in female patients

May 21, 1998

Intron A/Rebetol combination shows promise in treatment-naive patients

May 21, 1998

T-593 exhibits antiulcer activity via a dual mechanism of action

May 21, 1998

REFAC Biochemics and NYHQ will evaluate Pyloricide for the treatment of peptic ulcers

May 20, 1998

Novel prokinetic agent, R-93877, accelerates upper gut and colonic transit in humans

May 20, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...